NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

The Cleveland Cardiometabolic Cohort

CompletedN/A

Sponsor: University Hospitals Cleveland Medical Center

Conditions: HIV, Lipodystrophy

Interventions: Dual-energy X-ray absorptiometry

Countries: United States

In this observational study, the investigators will examine the changes in body composition in HIV-infected subjects before and after initiation of HIV treatment, and look at the correlations with changes in cardiometabolic indices such as endothelial function and coronary calcium scoring.

Eligibility overview

Sex: ALL

Age: 16 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* HIV-1 infection as documented by any licensed ELISA test kit and confirmed by Western blot at any time prior to study entry. HIV-1 culture, HIV-1 antigen, plasma HIV-1 RNA, or a second antibody test by a method other than ELISA is acceptable as an alternative confirmatory test
* Provides written informed consent and is capable of reading and comprehending the informed consent
* Is not currently taking antiretroviral therapy and has never been on such treatments in the past. Exception would be for subjects who had been in the past on ≤30 days cumulative antiretrovirals, as long as these were stopped \>6 months prior to study entry
* Is planning on starting antiretroviral therapy as part of routine clinic care

Exclusion Criteria:

* Pregnancy or lactation

Locations (1)

Cleveland, Ohio, United States